Loading clinical trials...

Minocycline As Adjunctive Treatment for Treatment Resistant Depression | Clinical Trials | Clareo Health

COMPLETEDPhase 3NCT03947827

Minocycline As Adjunctive Treatment for Treatment Resistant Depression

Major depressive disorder (MDD) is a leading cause of disability worldwide. Up to 50% of patients experience treatment resistant depression (TRD), which accounts for a vast majority of disease burden....

Lead sponsor: Centre for Addiction and Mental Health•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 3

Ketamine Augmentation of ECT in Treatment-Resistant Depression

NCT07088380 · Major Depressive Disorder, Treatment Resistant Depression

RECRUITINGPhase 1

Psilocybin for Treatment-Resistant Depression in Autism

NCT06731621 · Treatment Resistant Depression, Autism Spectrum Disorder

RECRUITING

Characterizing Dopamine Receptor Binding in Treatment Resistant Depression

NCT03537794 · Treatment Resistant Depression

RECRUITING

University of Iowa Interventional Psychiatry Service Patient Registry

NCT04480918 · Treatment Resistant Depression, Major Depressive Episode, and more

RECRUITINGPhase 3

Biomarker-guided rTMS for Treatment Resistant Depression

NCT04041479 · Treatment Resistant Depression, Major Depressive Disorder

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 9, 2025Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE3

Enrollment76

Start dateFeb 2020

Last updatedJan 9, 2025

Condition

Treatment Resistant Depression

Locations shown

Centre for Addiction and Mental Health

Toronto, Ontario

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 9, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions